治疗性低温后新生儿脑病磁共振生物标志物预测价值随扫描时机比较
该回顾性研究纳入98例胎龄35-41周接受治疗性低温的新生儿脑病患儿,分别在生后24-96小时和7-14天进行弥散加权成像和质子磁共振波谱,评估深部灰质ADC值、tNAA、乳酸、胆碱浓度及乳酸/tNAA、tNAA/胆碱比值对18-22月龄不良结局(死亡或神经发育损害)的预测准确性;深部灰质tNAA浓度预测价值最佳,AUC在24-96小时为0.97、7-14天为1.00,而ADC值、乳酸及乳酸/tNAA比值仅在24-96小时具有较高预测价值。
要点
- 深部灰质tNAA浓度在生后2周内均为最准确的定量MR预后标志物。
- 生后24-96小时ADC值、乳酸及乳酸/tNAA比值也具有较高预后价值。
- 生后7-14天仅tNAA保持高预后价值,ADC值等预测价值下降。
核心结论
- 生后2周内深部灰质tNAA浓度是预测治疗性低温后新生儿脑病不良结局最准确的定量MR生物标志物。
研究设计与样本
- 回顾性研究纳入98例胎龄35-41周接受治疗性低温的新生儿脑病患儿。
- 生后24-96小时(n=56)和7-14天(n=92)分别进行弥散加权成像和质子MR波谱,评估深部灰质ADC值、tNAA、乳酸、胆碱浓度及乳酸/tNAA、tNAA/胆碱比值。
- 不良结局定义为18-22月龄时死亡或神经发育损害,采用受试者工作特征曲线评估各MR生物标志物的预后准确性。
主要发现
- 深部灰质tNAA浓度预后价值最佳,AUC在24-96小时为0.97、7-14天为1.00。
- 生后24-96小时ADC值、乳酸浓度及乳酸/tNAA比值的AUC分别为0.90、0.95、0.97。
- 生后7-14天ADC值、乳酸及乳酸/tNAA比值的AUC分别为0.61、0.67、0.80,低于24-96小时。
临床怎么用
- 对于接受治疗性低温的新生儿脑病患儿,生后2周内均可依据深部灰质tNAA浓度进行预后评估。
- 生后24-96小时可结合ADC值、乳酸及乳酸/tNAA比值辅助预测不良结局。
- 生后7-14天应优先采用tNAA浓度而非ADC值或乳酸相关指标进行预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the optimal quantitative magnetic resonance (MR) biomarker in neonatal encephalopathy following therapeutic hypothermia based on scan timing. STUDY DESIGN: This retrospective study included 98 neonates (35-41 weeks of gestation) with neonatal encephalopathy, who underwent therapeutic hypothermia; diffusion-weighted imaging and proton MR spectroscopy were performed at 24-96 hours (n = 56) and 7-14 days (n = 92) after birth, respectively, to estimate apparent diffusion coefficient (ADC) values, N-acetylaspartate and N-acetylaspartylglutamate (tNAA), lactate, and choline concentrations, and lactate/tNAA, tNAA/choline ratios in the deep gray matter. Adverse outcomes included death or neurodevelopmental impairment at 18-22 months of age. We used receiver operating characteristic curves to examine the prognostic accuracy of each MR biomarker. RESULTS: Deep gray matter tNAA concentrations showed the best prognostic value, with an area under the curve (AUC) of 0.97 and 1.00 at 24-96 hours and 7-14 days after birth, respectively. At 24-96 hours of age, ADC values, lactate concentrations, and lactate/tNAA ratios showed prognostic value with AUCs of 0.90, 0.95, and 0.97, respectively. At 7-14 days of age, the AUCs of ADC values, lactate, and lactate/tNAA ratios were 0.61, 0.67, and 0.80, respectively; these were lower than those at 24-96 hours of age. CONCLUSIONS: During the first 2 weeks of life, the deep gray matter tNAA concentration was the most accurate quantitative MR biomarker. Although ADC values, lactate levels, and lactate/tNAA ratios also showed high prognostic value during 24-96 hours of life, only tNAA retained high prognostic value in the second week of life.
引用
- Shibasaki J, Niwa T, Piedvache A, et al. Comparison of Predictive Values of Magnetic Resonance Biomarkers Based on Scan Timing in Neonatal Encephalopathy Following Therapeutic Hypothermia. J Pediatr. 2021. PMID: 34391766. doi:10.1016/j.jpeds.2021.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。